Can the results be affected by other factors?

The test focuses on genes, so environmental factors or lifestyle do not directly affect the results.

What are the risks of the test?

Risks are minimal and mostly limited to sample collection; there are no direct risks related to the genetic analysis itself.

What do the results mean?

Results may indicate an increased risk of developing the disease, but do not necessarily mean the person will develop Alzheimer’s. They should be discussed with a specialized physician.

Alzheimer's Genetic Panel | Lahalak Platform

Lahalak Medical PlatformDifferentiate Care

Medical notice: this information is for education and service understanding. It is not a diagnosis or a recommendation for an unnecessary procedure.

About this service

The Alzheimer Disease Genetics Panel is a genetic test used to identify genetic mutations associated with an increased risk of developing Alzheimer's disease. The test examines specific genes such as APP, PSEN1, and PSEN2, which play a role in the development of the disease. This test is an important tool in assessing genetic risk, helping both doctors and patients make informed decisions regarding diagnosis and care. It also raises family awareness about the potential for developing the disease and facilitates appropriate future planning.

Purpose Test

Genetic Identification: Detecting mutations in genes such as APP, PSEN1, and PSEN2, which are linked to early-onset hereditary forms of the disease.
Risk Assessment: Estimating the individual’s risk of developing Alzheimer’s based on family history and genetic results.
Treatment Guidance: Assisting doctors in developing personalized treatment plans based on individual risk.
Family Information: Providing families with insights into the potential hereditary transmission of the disease.

Recommended groups

Individuals with a family history of the disease: People with first-degree relatives diagnosed with Alzheimer’s disease.
People with early symptoms: Such as memory loss or difficulty concentrating, especially at a young age.
Individuals seeking risk assessment: Those who want to understand their risk for personal or family planning purposes.
Participants in clinical studies: Researchers who need genetic evaluation as part of their studies.
Families planning to have children: To understand potential hereditary risks for their offspring.

Symptoms indicative

Memory loss: Difficulty remembering new information or recent events.
Cognitive disturbances: Problems with concentration or decision-making.
Behavioral changes: Such as depression, anxiety, or sudden mood swings.
Difficulty with daily tasks: Managing daily routines or performing complex tasks.
Language problems: Trouble finding the right words or expressing thoughts.

Normal Levels

Negative result: No known genetic mutations associated with Alzheimer’s are detected in the tested genes, suggesting a lower hereditary risk.
Positive result: Known genetic mutations are present that may increase the risk of developing the disease, requiring further discussion and planning with a specialist physician.

What is included?

✓Alzheimer Disease Genetics Panel Test
✓The optimal health guidance based on the result.
✓Personal support services from Lahalak

Conditions and notices

Fasting is not required
The terms and conditions announced on the "Lahalak" medical platform apply.
There are no special conditions for the service other than those mentioned.

Frequently Asked Questions

Short answers to the FAQs published with this service.

What is the purpose of this test?

The test aims to identify genetic mutations associated with an increased risk of developing Alzheimer’s disease.

How is the test performed?

A blood or saliva sample is collected and sent to the laboratory for analysis of the relevant genes.

Does the test require any special preparation?

Usually, no special preparation is needed, but it is recommended to follow the doctor’s instructions.

How long does it take to get the results?

Results typically take 2 to 4 weeks, depending on the laboratory.

Service resources and references

References and additional resources

Reference material and files associated with this service when available.

Scientific references

Bertram, L., & Tanzi, R. E. (2008). Alzheimer disease: Genome-wide association studies and the genetics of risk. Nature Reviews Genetics, 9, 357–370.
Van Cauwenberghe, C., Van Broeckhoven, C., & Sleegers, K. (2016). The genetic landscape of Alzheimer disease: Clinical applications of gene panels. Nature Reviews Neurology, 12, 519–531.
Karch, C. M., & Goate, A. M. (2015). Alzheimer’s disease risk genes and mechanisms of disease pathogenesis. Biological Psychiatry, 77, 43–51.
Naj, A. C., et al. (2011). Common variants at MS4A4/MS4A6E, CD2AP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease. Nature Genetics, 43, 436–441.

Alzheimer’s Genetic Risk Panel

About this service

Purpose Test

Recommended groups

Symptoms indicative

Normal Levels

What is included?

Conditions and notices

Frequently Asked Questions

References and additional resources

Scientific references

Choose a provider and branch

Let us help you

Didn’t find the service?

Services you might also like

Advanced Chromosome 10p FISH Testing

Decode Your CSTB Genetic Profile

Check Your Genetic Health

Phytanic Acid Test

Your opinion matters

Was this content helpful?

Have a note?